Tiroid Fırtınası

Authors

Ayça Çalbay
https://orcid.org/0000-0002-7031-2689

Synopsis

Thyroid storm is an endocrinological emergency characterized by severe and acute adrenergic hyperactivity developing due to one or more underlying triggering factors and posing a life-threatening risk. Its most common primary cause is Graves' disease with a rate of 85%, while toxic multinodular and nodular goiter are also among the causes; secondary causes include overproduction of TSH/TRH originating from the hypothalamus or pituitary gland, as well as thyroiditis. While infections are the most frequent trigger, surgical procedures, trauma, irregular use or discontinuation of antithyroid drugs, pregnancy/delivery, and iodine applications can also lead to a storm. Clinical presentation features markedly high fever (40-41°C), tachycardia disproportionate to body temperature, arrhythmias (especially atrial fibrillation and sinus tachycardia), nausea, vomiting, diarrhea, and central nervous system disturbances ranging from agitation to coma. Diagnosis is established based on the clinical picture accompanied by suppressed TSH and elevated free T3 and T4 levels; the Burch and Wartofsky scoring system is used to determine diagnostic probability. Because the mortality rate ranges between 10-30%, treatment of all patients must be managed in intensive care units. The treatment approach encompasses supportive care with fluids, dextrose, and thiamine; suppression of hormone synthesis and release with thionamides (propylthiouracil, methimazole); inhibition of new hormone production with iodine solutions (Lugol); peripheral beta-adrenergic blockade with propranolol; prevention of peripheral T4 to T3 conversion with glucocorticoids; and plasmapheresis in refractory cases.

References

Akamizu T, Satoh T, Isozaki O, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 2012; 22:661.

Swee du S, Chng CL, Lim A. Clinical characteristics and outcome of thyroid storm: a case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr Pract 2015; 21:182

Rivas AM, Larumbe E, Thavaraputta S, et al. Unfavorable Socioeconomic Factors Underlie High Rates of Hospitalization for Complicated Thyrotoxicosis in Some Regions of the United States. Thyroid 2019; 29:27.

Akamizu T. Thyroid Storm: A Japanese Perspective. Thyroid 2018; 28:32

Galindo RJ, Hurtado CR, Pasquel FJ, et al. National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004-2013. Thyroid 2019; 29:36

Angell TE, Lechner MG, Nguyen CT, et al. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab 2015; 100:451.

Ono Y, Ono S, Yasunaga H, et al. Factors Associated With Mortality of Thyroid Storm: Analysis Using a National Inpatient Database in Japan. Medicine (Baltimore) 2016; 95:e2848.

Ngo SY, Chew HC. When the storm passes unnoticed--a case series of thyroid storm. Resuscitation 2007; 73:485

Burch HB, Wartofsky L: Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 22: 263, 1993

Wald D: ECG manifestations of selected metabolic and endocrine disorders. Emerg Med Clin North Am 24: 145, 2006

Tietgens ST, Leinung MC: Thyroid storm. Med Clin North Am 79: 169, 1995

Cooper DS: Antithyroid drugs. N Engl J Med 352: 905, 2005

Hodak SP, Huang C, Clarke D, et al: Intravenous methimazole in the treatment of refractory hyperthyroidism. Thyroid 16: 691, 2006

Dillmann WH: Thyroid storm. Curr Ther Endocrinol Metab 6: 81, 1997

Tajiri J, Katsuya H, Kiyokawa T, et al: Successful treatment of thyrotoxic crisis with plasma exchange. Crit Care Med 12: 536, 1984

Pages

65-76

Published

June 1, 2021

License

License